Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer. [electronic resource]
Producer: 20191206Description: 236-242 p. digitalISSN:- 2374-2445
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bevacizumab -- administration & dosage
- Capecitabine -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Cost-Benefit Analysis
- Disease Progression
- Drug Costs
- Female
- Humans
- Maintenance Chemotherapy -- economics
- Male
- Markov Chains
- Medicare -- economics
- Middle Aged
- Models, Economic
- Neoplasm Metastasis
- Quality of Life
- Quality-Adjusted Life Years
- Randomized Controlled Trials as Topic
- Time Factors
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.